Agit, Glooma and Gripwise to go on roadshow in China
|
12 APR 2024
|
Intel ID : 390260
|
||||
| Intel ID | 390260 | ||
| Value | ND | ||
| Native Currency | Euro (EUR) | ||
|
Financial Data - Glooma
(31 Dec 2022) |
Revenue: EUR 0,08m EBITDA: EUR 0,03m Net Debt: EUR 0,04m People: 2 |
||
| Date |
 |
||
| Country | |
||
| Geography |  |
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Subsector (TTRSC) |
30.02.04 Medical Diagnostic Equipment (Primary) 30 Healthcare / 30.02 Healthcare Equipment & Supplies |
||
| Secondary Subsectors (TTRSC) |
30.01.99 Other Biotechnology & Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 40.03.99 Other Internet, Software & IT Services 40 Information Technology / 40.03 Internet, Software & IT Services 10.01.03 Distributors & Wholesalers (B2B) 10 Business Services / 10.01 Business & Professional Support Services |
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
40.03.99 Other Internet, Software & IT Services 40 Information Technology / 40.03 Internet, Software & IT Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.02.04 Medical Diagnostic Equipment 30 Healthcare / 30.02 Healthcare Equipment & Supplies |
||
| Secondary Sectors (TTRSC) |
30.01.99 Other Biotechnology & Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
10.01.03 Distributors & Wholesalers (B2B) 10 Business Services / 10.01 Business & Professional Support Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.